Xiaoyong Lu
Company: Eli Lilly & Co.
Job title: Director - Oligonucleotide & Genetic Medicine
Seminars:
WORKSHOP A: Exploring & Optimizing the Pairing of Targeting Moiety & Target Biology 9:00 am
With such a wide variety of next-generation conjugates being developed, a key consideration for the lesser understood formats in novel conjugates is the target selection. If you are going to make one correct decision during the drug development process, selecting the right target is crucial for clinical success. By ensuring an improved understanding of different…Read more
day: Pre-Conference Day Track 2